SCHEMBL16791990

SCHEMBL16791990

COc1cnccc1C#CCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 6/20 0.50
▸ CYP2C19 P33261 6/20 0.50
▸ CYP1A2 P05177 5/20 0.50
▸ CYP2E1 P05181 5/20 0.50
▸ CYP2B6 P20813 5/20 0.50
▸ CYP2C9 P11712 5/20 0.50
▸ CYP2D6 P10635 5/20 0.36
▸ CYP2C8 P10632 4/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ EGFR P00533 1/20 0.36
▸ MELK Q14680 1/20 0.35
▸ ASIC3 Q9UHC3 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ MAPK14 Q16539 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23266142 0.77 ALDH1A1 (0.47) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL6133271 0.74 CYP2A6 (0.69) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL4861567 0.73 ATM (0.47) CYP1A2CYP3A4CA12CA1CA2
SCHEMBL1838731 0.72 PTGDR2 (0.41) CYP2C19CYP1A2CYP2C9CYP3A4EGFR
SCHEMBL1046287 0.72 CYP2E1 (0.38) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL9662866 0.71 CYP1A2 (0.44) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL1024738 0.71 CLK1 (0.44) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL28123379 0.71 CYP1A2 (0.47) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL29530507 0.71 CLK1 (0.44) CYP2A6CYP2C19CYP1A2CYP2E1CYP2B6
SCHEMBL16791726 0.69 PTGDR2 (0.50) CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080132-A1 BROMODOMAIN INHIBITORS AbbVie Inc. (US) 2016-10-19 — — EP disclosed
WO-2015085925-A1 BROMODOMAIN INHIBITORS ABBVIE INC. (US) 2015-06-18 — — WO disclosed
Send feedback